SCICLONE PHARMACEUTICALS INC Financing Cash Flow
SCICLONE PHARMACEUTICALS INC reported Financing Cash Flow of -$8.35 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2014-03-17
- SCICLONE PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2013-06-30 was $603.00K.
- SCICLONE PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2013-03-31 was -$1.83M.
- SCICLONE PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2012-12-31 was -$4.68M.
- SCICLONE PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2012-09-30 was -$13.98M, a 2066.81% decline year-over-year.
- SCICLONE PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2013 was -$8.35M.
- SCICLONE PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2012 was -$24.70M, a 973.68% decline from fiscal 2011.
- SCICLONE PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2011 was $2.83M, a 27.53% decline from fiscal 2010.
- SCICLONE PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2010 was $3.90M, a 48.61% increase from fiscal 2009.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2013-12-31 | -$8.35M 10-K · filed 2014-03-17 | |||
| 2013-06-30 | $603.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$1.23M 10-Q · filed 2013-08-09 | -$5.91M derived: sum of 3 quarters · filed 2014-03-17 | -$19.89M derived: sum of 4 quarters · filed 2014-03-17 |
| 2013-03-31 | -$1.83M 10-Q · filed 2013-08-09 | -$6.51M derived: sum of 2 quarters · filed 2014-03-17 | -$20.50M derived: sum of 3 quarters · filed 2014-03-17 | -$25.82M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-12-31 | -$4.68M derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-03-17 | -$18.67M derived: sum of 2 quarters · filed 2014-03-17 | -$23.99M derived: sum of 3 quarters · filed 2014-03-17 | -$24.70M 10-K · filed 2014-03-17 |
| 2012-09-30 | -$13.98M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2013-04-01 | -$19.30M derived: sum of 2 quarters · filed 2013-08-09 | -$20.02M 10-Q/A · filed 2013-04-01 | -$23.21M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | -$5.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$6.03M 10-Q · filed 2013-08-09 | -$9.22M derived: sum of 3 quarters · filed 2014-03-17 | -$8.51M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | -$710.00K 10-Q · filed 2013-08-09 | -$3.90M derived: sum of 2 quarters · filed 2014-03-17 | -$3.19M derived: sum of 3 quarters · filed 2014-03-17 | $2.01M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | -$3.19M derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-03-17 | -$2.48M derived: sum of 2 quarters · filed 2014-03-17 | $2.72M derived: sum of 3 quarters · filed 2014-03-17 | $2.83M 10-K · filed 2014-03-17 |
| 2011-09-30 | $711.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-04-01 | $5.91M derived: sum of 2 quarters · filed 2013-04-01 | $6.02M 10-Q/A · filed 2013-04-01 | $8.81M derived: sum of 4 quarters · filed 2013-04-01 |
| 2011-06-30 | $5.20M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-04-01 | $5.31M 10-Q/A · filed 2013-04-01 | $8.10M derived: sum of 3 quarters · filed 2013-04-01 | $8.16M derived: sum of 4 quarters · filed 2013-04-01 |
| 2011-03-31 | $106.00K 10-Q/A · filed 2013-04-01 | $2.90M derived: sum of 2 quarters · filed 2013-04-01 | $2.95M derived: sum of 3 quarters · filed 2013-04-01 | |
| 2010-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $2.85M derived: sum of 2 quarters · filed 2013-04-01 | $3.90M 10-K · filed 2013-04-01 | |
| 2010-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $1.11M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $1.05M 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $2.63M 10-K · filed 2012-03-15 |